BRIACELL THERAP (BCTX) vs Context Therapeutics Inc. (CNTX)
BRIACELL THERAP and Context Therapeutics Inc. are both Biotechnology companies. BRIACELL THERAP and Context Therapeutics Inc. are of similar size ($37.2M and $34.1M). Context Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.9×. Across the 9 metrics below, Context Therapeutics Inc. leads on 5 and BRIACELL THERAP on 4.
Valuation
Profitability
| Metric | BCTX | CNTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (173.55%) | (76.14%) | (57.72%) |
| Return on assets | (139.20%) | (68.96%) | (49.22%) |
| Return on invested capital | (3,311.00%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack